Genetic Polymorphism in CYP2D6 and Its Association With the Safety and Efficacy of Fluvoxamine in Patients With Major Depressive Disorder . Precis. Med. Com. 2023, 3 (1), 43-49. https://doi.org/10.55627/pmc.003.01.0301.